Edwards Lifesciences Corporation (EW) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 598.70M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 13.87B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $598.70M | (m) | (m) | $13.87B | (m) |
| 2026-03-31 | (m) | (m) | (m) | $598.50M | (m) | (m) | $13.32B | (m) |
| 2025-12-31 | (m) | (m) | (m) | $598.30M | (m) | (m) | $13.70B | (m) |
| 2025-09-30 | (m) | (m) | (m) | $598.20M | (m) | (m) | $13.27B | (m) |
| 2025-06-30 | (m) | (m) | (m) | $598.00M | (m) | (m) | $13.49B | (m) |
| 2025-03-31 | (m) | (m) | (m) | $597.80M | (m) | (m) | $13.02B | (m) |
| 2024-12-31 | (m) | (m) | (m) | $597.70M | (m) | (m) | $13.06B | (m) |
| 2024-09-30 | (m) | (m) | (m) | $597.50M | (m) | (m) | $12.97B | (m) |
| 2024-06-30 | (m) | (m) | (m) | $597.30M | (m) | (m) | $10.10B | (m) |
| 2024-03-31 | (m) | (m) | (m) | $597.20M | (m) | (m) | $9.74B | (m) |
| 2023-12-31 | (m) | (m) | (m) | $597.00M | (m) | (m) | $9.36B | (m) |
| 2023-09-30 | (m) | (m) | (m) | $596.80M | (m) | (m) | $9.37B | (m) |
| 2023-06-30 | (m) | (m) | (m) | $596.70M | (m) | (m) | $9.00B | (m) |
| 2023-03-31 | (m) | (m) | (m) | $596.50M | (m) | (m) | $8.65B | (m) |
| 2022-12-31 | (m) | (m) | (m) | $596.30M | (m) | (m) | $8.29B | (m) |
| 2022-09-30 | (m) | (m) | (m) | $596.20M | (m) | (m) | $8.64B | (m) |
| 2022-06-30 | (m) | (m) | (m) | $596.00M | (m) | (m) | $8.43B | (m) |
| 2022-03-31 | (m) | (m) | (m) | $595.90M | (m) | (m) | $8.42B | (m) |
| 2021-12-31 | (m) | (m) | (m) | $595.70M | (m) | (m) | $8.50B | (m) |
| 2021-09-30 | (m) | (m) | (m) | $595.50M | (m) | (m) | $8.16B | (m) |
| 2021-06-30 | (m) | (m) | (m) | $595.40M | (m) | (m) | $7.66B | (m) |
| 2021-03-31 | (m) | (m) | (m) | $595.20M | (m) | (m) | $7.21B | (m) |
| 2020-12-31 | (m) | (m) | (m) | $595.00M | (m) | (m) | $7.24B | (m) |
| 2020-09-30 | (m) | (m) | (m) | $594.90M | (m) | (m) | $6.80B | (m) |
| 2020-06-30 | (m) | (m) | (m) | $594.70M | (m) | (m) | $6.42B | (m) |
| 2020-03-31 | (m) | (m) | (m) | $594.60M | (m) | (m) | $6.08B | (m) |
| 2019-12-31 | (m) | (m) | (m) | $594.40M | (m) | (m) | $6.49B | (m) |
| 2019-09-30 | (m) | (m) | (m) | $594.20M | (m) | (m) | $5.97B | (m) |
| 2019-06-30 | (m) | (m) | (m) | $594.10M | (m) | (m) | $5.57B | (m) |
| 2019-03-31 | (m) | (m) | (m) | $593.90M | (m) | (m) | $5.47B | (m) |
| 2018-12-31 | (m) | (m) | $0.00 | $593.80M | (m) | (m) | $5.32B | (m) |
| 2018-09-30 | (m) | (m) | $599.90M | $593.60M | (m) | (m) | $5.96B | (m) |
| 2018-06-30 | (m) | (m) | $599.20M | $593.90M | (m) | (m) | $5.69B | (m) |
| 2018-03-31 | (m) | (m) | $598.60M | $456.00M | (m) | (m) | $5.83B | (m) |
| 2017-12-31 | (m) | (m) | $598.00M | $438.40M | (m) | (m) | $5.70B | (m) |
| 2017-09-30 | (m) | (m) | (m) | $1.03B | (m) | (m) | $5.49B | (m) |
| 2017-06-30 | (m) | (m) | (m) | $1.02B | (m) | (m) | $5.14B | (m) |
| 2017-03-31 | (m) | (m) | (m) | $847.90M | (m) | (m) | $4.78B | (m) |
| 2016-12-31 | (m) | (m) | (m) | $822.30M | (m) | (m) | $4.51B | (m) |
| 2016-09-30 | (m) | (m) | (m) | $600.60M | (m) | (m) | $4.34B | (m) |
| 2016-06-30 | (m) | (m) | (m) | $602.50M | (m) | (m) | $4.05B | (m) |
| 2016-03-31 | (m) | (m) | (m) | $602.20M | (m) | (m) | $3.85B | (m) |
| 2015-12-31 | (m) | (m) | (m) | $599.90M | (m) | (m) | $4.06B | (m) |
| 2015-09-30 | (m) | (m) | (m) | $604.90M | (m) | (m) | $3.88B | (m) |
| 2015-06-30 | (m) | (m) | (m) | $600.30M | (m) | (m) | $3.61B | (m) |
| 2015-03-31 | (m) | (m) | (m) | $602.70M | (m) | (m) | $3.49B | (m) |
| 2014-12-31 | (m) | (m) | (m) | $598.10M | (m) | (m) | $3.52B | (m) |
| 2014-09-30 | (m) | (m) | (m) | $596.40M | (m) | (m) | $3.35B | (m) |
| 2014-06-30 | (m) | (m) | (m) | $598.00M | (m) | (m) | $3.33B | (m) |
| 2014-03-31 | (m) | (m) | (m) | $725.40M | (m) | (m) | $2.65B | (m) |
| 2013-12-31 | (m) | (m) | (m) | $593.10M | (m) | (m) | $2.72B | (m) |
| 2012-12-31 | (m) | (m) | (m) | $189.30M | (m) | (m) | $2.22B | (m) |
| 2010-06-30 | (m) | (m) | (m) | $177.50M | (m) | (m) | $1.64B | (m) |
| 2009-12-31 | (m) | (m) | (m) | $90.30M | (m) | (m) | $1.62B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |